SXTC
China SXT Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.89
-0.24 ▼ -11.27%
🌙 3월 13일 7:31 PM ET (한국 3/14 08:31)
$1.93
+0.04 ▲ +2.12%
| Index | - | P/E | - | EPS (ttm) | -35.49 | Insider Own | 35.33% | Shs Outstand | 0.00B | Perf Week | -7.35% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.00B | Perf Month | -24.1% |
| Enterprise Value | -0.02B | PEG | - | EPS next Q | - | Inst Own | 0.23% | Short Float | 8.48% | Perf Quarter | -99.1% |
| Income | -0.01B | P/S | 1.18 | EPS this Y | - | Inst Trans | 1.32% | Short Ratio | 0.18 | Perf Half Y | -99.27% |
| Sales | 0.00B | P/B | 0.07 | EPS next 5Y | - | ROA | -30.93% | Short Interest | 0.05M | Perf YTD | -99.21% |
| Book/sh | 26.16 | P/C | 0.09 | EPS past 3/5Y | 95.28% 79.65% | ROE | -50.3% | 52W High | -99.82% ($1046.98) | Perf Year | -99.55% |
| Cash/sh | 22.14 | P/FCF | - | Sales past 3/5Y | -12.54% -19.54% | ROIC | -43.5% | 52W Low | 0.53% ($1.88) | Perf 3Y | -99.98% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -101.08% | Gross Margin | 21.74% | Volatility(W/M) | 7.83% 10.24% | Perf 5Y | -100% |
| Dividend TTM | - | EV/Sales | -11.81 | Sales Y/Y TTM | -15.42% | Oper. Margin | -479.53% | ATR (14) | 4.24 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.06 | EPS Q/Q | - | Profit Margin | -576.72% | RSI (14) | 24.52 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.37 | Sales Q/Q | - | SMA20 | -14.8% ($2.22) | Beta | 1.69 | Target Price | - |
| Payout | - | Debt/Eq | 0.06 | Earnings | - | SMA50 | -94.72% ($35.8) | Rel Volume | 0.19 | Prev Close | $2.13 |
| Employees | 75 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | - | SMA200 | -98.98% ($185.29) | Avg Volume(3M) | 0.29M | Price | $1.89 |
| IPO | 2019/1/4 | Option/Short | No/Yes | Trades | 406 | Volume | 55,320 | Change | -11.27% |
뉴스 로딩 중...